New paclitaxel-cisplatin based chemotherapy regimen for advanced stage, recurrent, or refractory neuroblastoma-preliminary report.
Surico
Giammarco
G
Department of Pediatric Hematology and Oncology, II Pediatric Clinic, University of Bari, Bari, Italy.
Muggeo
Paola
P
De Leonardis
Francesco
F
Rigillo
Nicola
N
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D019046:Bone Marrow Neoplasms / Q000188:drug therapy* / Q000473:pathology; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D002945:Cisplatin / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use*; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016879:Salvage Therapy; D043823:Taxoids
D043823:Taxoids; D017239:Paclitaxel; D002945:Cisplatin